| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3204309 | The Journal of Allergy and Clinical Immunology: In Practice | 2014 | 7 Pages |
Abstract
Once-daily treatment with FFNS over 52 weeks in prepubescent children resulted in a small reduction in growth velocity compared with placebo. Clinicians will need to balance the reduction in growth observed with FFNS to its potential for clinical benefit.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Laurie A. MD, Richard MD, Jorge MD, Diane BS, Anna BS, Soren MD,